SOAT1 and colorectal carcinoma: Moreover, the degree of inhibition of JAK-STAT signaling in the combined group (p-value PRO+CAP = 0.004 versus the control) was greater than that of PRO alone (p-value = 0.01 versus control), which supports the benefits of using the double combination therapy approach in treating BRAFV600E-mutant mt CRC.